Enzymatic and non-enzymatic functions of the lysyl oxidase family in bone

Matrix Biology

Volumn 52-54, Issue , 2016, Pages 7-18

  Trackman, Philip C ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Angiogenesis; Bone; Cell differentiation; Cell proliferation; Collagen; Lysyl oxidase; Progenitor cell

Indexed keywords

COLLAGEN; DEOXYPYRIDINOLINE; ELASTIN; HYDROXYLYSINE; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE; PROTEIN LYSINE 6 OXIDASE; PYRIDINOLINE;

ANGIOGENESIS; ARTICLE; BONE CHARACTERISTICS AND FUNCTIONS; BONE DENSITY; BONE DEVELOPMENT; BONE MARROW CELL; BONE MARROW PROGENITOR CELL; BONE MARROW STROMA CELL; BONE METASTASIS; BONE STRENGTH; BONE STRUCTURE; CARTILAGE CELL; CATALYSIS; CONNECTIVE TISSUE; CROSS LINKING; DIABETES MELLITUS; ENCHONDRAL OSSIFICATION; ENZYME ACTIVITY; GLYCATION; GLYCOSYLATION; HOMEOSTASIS; HUMAN; NEOPLASM; NONHUMAN; NUCLEOPHILICITY; OSTEOBLAST; OSTEOPENIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TENSILE STRENGTH; TUMOR GROWTH; ANIMAL; BONE; CYTOLOGY; ENZYMOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; BONE AND BONES; COLLAGEN; ELASTIN; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN-LYSINE 6-OXIDASE; STEM CELLS;

EID: 84955256640     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2016.01.001     Document Type: Article

References (97)

1. Paschalis E.P., Tatakis D.N., Robins S., Fratzl P., Manjubala I., Zoehrer R., Gamsjaeger S., Buchinger B., Roschger A., Phipps R., Boskey A.L., Dall'Ara E., Varga P., Zysset P., Klaushofer K., Roschger P. Lathyrism-induced alterations in collagen cross-links influence the mechanical properties of bone material without affecting the mineral. Bone 2011, 49:1232-1241.
2. Oxlund H., Barckman M., Ortoft G., Andreassen T.T. Reduced concentrations of collagen cross-links are associated with reduced strength of bone. Bone 1995, 17:365s-371s.
3. McNerny E.M., Gong B., Morris M.D., Kohn D.H. Bone fracture toughness and strength correlate with collagen cross-link maturity in a dose-controlled lathyrism mouse model. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2015, 30:455-464.
4. Saito M., Marumo K. Effects of collagen crosslinking on bone material properties in health and disease. Calcif. Tissue Int. 2015, 97:242-261.
5. Alford A.I., Kozloff K.M., Hankenson K.D. Extracellular matrix networks in bone remodeling. Int. J. Biochem. Cell Biol. 2015, 65:20-31.
6. Garnero P. The role of collagen organization on the properties of bone. Calcif. Tissue Int. 2015, 97:229-240.
7. Uzawa K., Grzesik W.J., Nishiura T., Kuznetsov S.A., Robey P.G., Brenner D.A., Yamauchi M. Differential expression of human lysyl hydroxylase genes, lysine hydroxylation, and cross-linking of type I collagen during osteoblastic differentiation in vitro. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 1999, 14:1272-1280.
8. Pornprasertsuk S., Duarte W.R., Mochida Y., Yamauchi M. Lysyl hydroxylase-2b directs collagen cross-linking pathways in MC3T3-E1 cells. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2004, 19:1349-1355.
9. van der Slot A.J., Zuurmond A.M., Bardoel A.F., Wijmenga C., Pruijs H.E., Sillence D.O., Brinckmann J., Abraham D.J., Black C.M., Verzijl N., DeGroot J., Hanemaaijer R., TeKoppele J.M., Huizinga T.W., Bank R.A. Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J. Biol. Chem. 2003, 278:40967-40972.
10. Heikkinen J., Risteli M., Wang C., Latvala J., Rossi M., Valtavaara M., Myllyla R. Lysyl hydroxylase 3 is a multifunctional protein possessing collagen glucosyltransferase activity. J. Biol. Chem. 2000, 275:36158-36163.
11. Sricholpech M., Perdivara I., Nagaoka H., Yokoyama M., Tomer K.B., Yamauchi M. Lysyl hydroxylase 3 glucosylates galactosylhydroxylysine residues in type I collagen in osteoblast culture. J. Biol. Chem. 2011, 286:8846-8856.
12. Lucero H.A., Kagan H.M. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell. Mol. Life Sci. 2006, 63:2304-2316.
13. Eyre D.R., Paz M.A., Gallop P.M. Cross-linking in collagen and elastin. Annu. Rev. Biochem. 1984, 53:717-748.
14. Liu X., Zhao Y., Gao J., Pawlyk B., Starcher B., Spencer J.A., Yanagisawa H., Zuo J., Li T. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat. Genet. 2004, 36:178-182.
15. Bignon M., Pichol-Thievend C., Hardouin J., Malbouyres M., Brechot N., Nasciutti L., Barret A., Teillon J., Guillon E., Etienne E., Caron M., Joubert-Caron R., Monnot C., Ruggiero F., Muller L., Germain S. Lysyl oxidase-like protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane. Blood 2011, 118:3979-3989.
16. Nagan N., Kagan H.M. Modulation of lysyl oxidase activity toward peptidyl lysine by vicinal dicarboxylic amino acid residues. Implications for collagen cross-linking. J. Biol. Chem. 1994, 269:22366-22371.
17. Siegel R.C. Biosynthesis of collagen crosslinks: increased activity of purified lysyl oxidase with reconstituted collagen fibrils. Proc. Natl. Acad. Sci. U. S. A. 1974, 71:4826-4830.
18. Narayanan A.S., Page R.C., Kuzan F., Cooper C.G. Elastin cross-linking in vitro. Studies on factors influencing the formation of desmosines by lysyl oxidase action on tropoelastin. Biochem. J. 1978, 173:857-862.
19. Kagan H.M., Tseng L., Trackman P.C., Okamoto K., Rapaka R.S., Urry D.W. Repeat polypeptide models of elastin as substrates for lysyl oxidase. J. Biol. Chem. 1980, 255:3656-3659.
20. Kagan H.M., Williams M.A., Williamson P.R., Anderson J.M. Influence of sequence and charge on the specificity of lysyl oxidase toward protein and synthetic peptide substrates. J. Biol. Chem. 1984, 259:11203-11207.
21. Li W., Nugent M.A., Zhao Y., Chau A.N., Li S.J., Chou I.N., Liu G., Kagan H.M. Lysyl oxidase oxidizes basic fibroblast growth factor and inactivates its mitogenic potential. J. Cell. Biochem. 2003, 88:152-164.
22. Atsawasuwan P., Mochida Y., Katafuchi M., Kaku M., Fong K.S., Csiszar K., Yamauchi M. Lysyl oxidase binds transforming growth factor-beta and regulates its signaling via amine oxidase activity. J. Biol. Chem. 2008, 283:34229-34240.
23. Kang A.H. Studies on the location of intermolecular cross-links in collagen. Isolation of a CNBr peptide containing hydroxylysinonorleucine. Biochemistry 1972, 11:1828-1835.
24. Wu J.J., Eyre D.R. Identification of hydroxypyridinium cross-linking sites in type II collagen of bovine articular cartilage. Biochemistry 1984, 23:1850-1857.
25. Nicholls A.C., Bailey A.J. Identification of cyanogen bromide peptides involved in intermolecular cross-linking of bovine type III collagen. Biochem. J. 1980, 185:195-201.
26. Knott L., Bailey A.J. Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance. Bone 1998, 22:181-187.
27. Yamauchi M., Sricholpech M. Lysine post-translational modifications of collagen. Essays Biochem. 2012, 52:113-133.
28. Gonzalez E., Hamabata A., Rojkind M. Some properties of the reactive hydroxylysyl residues in collagen: their possible role in nucleation during fibril formation. Coll. Relat. Res. 1984, 4:339-350.
29. Nagaoka H., Mochida Y., Atsawasuwan P., Kaku M., Kondoh T., Yamauchi M. 1,25(OH)2D3 regulates collagen quality in an osteoblastic cell culture system. Biochem. Biophys. Res. Commun. 2008, 377:674-678.
30. Saito M., Grynpas M.D., Burr D.B., Allen M.R., Smith S.Y., Doyle N., Amizuka N., Hasegawa T., Kida Y., Marumo K., Saito H. Treatment with eldecalcitol positively affects mineralization, microdamage, and collagen crosslinks in primate bone. Bone 2015, 73:8-15.
31. Terajima M., Perdivara I., Sricholpech M., Deguchi Y., Pleshko N., Tomer K.B., Yamauchi M. Glycosylation and cross-linking in bone type I collagen. J. Biol. Chem. 2014, 289:22636-22647.
32. Gerstenfeld L.C., Riva A., Hodgens K., Eyre D.R., Landis W.J. Post-translational control of collagen fibrillogenesis in mineralizing cultures of chick osteoblasts. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 1993, 8:1031-1043.
33. Wagenseil J.E., Mecham R.P. New insights into elastic fiber assembly. Birth Defects Res. C Embryo Today 2007, 81:229-240.
34. Rooker G.D., Steins G.N., Tate L.J., Keeley F.W. Biochemical identification of elastin in periosteum and pericranium. Clin. Orthop. Relat. Res. 1980, 152:292-295.
35. Frankenhuis-van den Heuvel T.H., Kuijpers-Jagtman A.M., Maltha J.C. Microscopic study of the rabbit mandibular periosteum and attached structures. Acta Anat. 1991, 142:33-40.
36. Chillemi C., Bevilacqua C., Gigante A. In vitro effects of elastase on periosteum of long bones: an histochemical, immunohistochemical and morphometric study. Eur. J. Histochem. 1999, 43:227-233.
37. Gigante A., Chillemi C., Quaglino D., Miselli M., Pasquali-Ronchetti I. DL-penicillamine induced alteration of elastic fibers of periosteum-perichondrium and associated growth inhibition: an experimental study. J. Orthop. Res. 2001, 19:398-404.
38. Cha H.M., Kim S.M., Choi Y.S., Kim D.I. Scaffold-free three-dimensional culture systems for mass production of periosteum-derived progenitor cells. J. Biosci. Bioeng. 2015, 120:218-222.
39. Larsen K.H., Frederiksen C.M., Burns J.S., Abdallah B.M., Kassem M. Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2010, 25:796-808.
40. Selye H. Lathyrism. Rev. Can. Biol. 1957, 16:1-82.
41. Bornstein P., Piez K.A. The nature of the intramolecular cross-links in collagen. The separation and characterization of peptides from the cross-link region of rat skin collagen. Biochemistry 1966, 5:3460-3473.
42. Pinnell S.R., Martin G.R. The cross-linking of collagen and elastin: enzymatic conversion of lysine in peptide linkage to alpha-aminoadipic-delta-semialdehyde (allysine) by an extract from bone. Proc. Natl. Acad. Sci. U. S. A. 1968, 61:708-716.
43. Mc K.G., Lalich J.J., Schilling E.D., Strong F.M. A crystalline "lathyrus factor" from Lathyrus odoratus. Arch. Biochem. Biophys. 1954, 52:313-322.
44. Tang S.S., Chichester C.O., Kagan H.M. Comparative sensitivities of purified preparations of lysyl oxidase and other amine oxidases to active site-directed enzyme inhibitors. Connect. Tissue Res. 1989, 19:93-103.
45. Tang S.S., Trackman P.C., Kagan H.M. Reaction of aortic lysyl oxidase with beta-aminopropionitrile. J. Biol. Chem. 1983, 258:4331-4338.
46. Trackman P.C., Kagan H.M. Nonpeptidyl amine inhibitors are substrates of lysyl oxidase. J. Biol. Chem. 1979, 254:7831-7836.
47. Tchaparian E.H., Uriu-Adams J.Y., Keen C.L., Mitchell A.E., Rucker R.B. Lysyl oxidase and P-ATPase-7A expression during embryonic development in the rat. Arch. Biochem. Biophys. 2000, 379:71-77.
48. Rucker R.B., Kosonen T., Clegg M.S., Mitchell A.E., Rucker B.R., Uriu-Hare J.Y., Keen C.L. Copper, lysyl oxidase, and extracellular matrix protein cross-linking. Am. J. Clin. Nutr. 1998, 67:996s-1002s.
49. Wang S.X., Mure M., Medzihradszky K.F., Burlingame A.L., Brown D.E., Dooley D.M., Smith A.J., Kagan H.M., Klinman J.P. A crosslinked cofactor in lysyl oxidase: redox function for amino acid side chains. Science 1996, 273:1078-1084.
50. Dubois J.L., Klinman J.P. Mechanism of post-translational quinone formation in copper amine oxidases and its relationship to the catalytic turnover. Arch. Biochem. Biophys. 2005, 433:255-265.
51. Mure M., Wang S.X., Klinman J.P. Synthesis and characterization of model compounds of the lysine tyrosyl quinone cofactor of lysyl oxidase. J. Am. Chem. Soc. 2003, 125:6113-6125.
52. Fujii K., Kajiwara T., Kurosu H. Effect of vitamin B6 deficiency on the crosslink formation of collagen. FEBS Lett. 1979, 97:193-195.
53. Panchenko M.V., Stetler-Stevenson W.G., Trubetskoy O.V., Gacheru S.N., Kagan H.M. Metalloproteinase activity secreted by fibrogenic cells in the processing of prolysyl oxidase. Potential role of procollagen C-proteinase. J. Biol. Chem. 1996, 271:7113-7119.
54. Uzel M.I., Scott I.C., Babakhanlou-Chase H., Palamakumbura A.H., Pappano W.N., Hong H.H., Greenspan D.S., Trackman P.C. Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures. J. Biol. Chem. 2001, 276:22537-22543.
55. Cronshaw A.D., Fothergill-Gilmore L.A., Hulmes D.J. The proteolytic processing site of the precursor of lysyl oxidase. Biochem. J. 1995, 306(Pt 1):279-284.
56. Fogelgren B., Polgar N., Szauter K.M., Ujfaludi Z., Laczko R., Fong K.S., Csiszar K. Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation. J. Biol. Chem. 2005, 280:24690-24697.
57. Maruhashi T., Kii I., Saito M., Kudo A. Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase. J. Biol. Chem. 2010, 285:13294-13303.
58. Borel A., Eichenberger D., Farjanel J., Kessler E., Gleyzal C., Hulmes D.J., Sommer P., Font B. Lysyl oxidase-like protein from bovine aorta. Isolation and maturation to an active form by bone morphogenetic protein-1. J. Biol. Chem. 2001, 276:48944-48949.
59. Lugassy J., Zaffryar-Eilot S., Soueid S., Mordoviz A., Smith V., Kessler O., Neufeld G. The enzymatic activity of lysyl oxidas-like-2 (LOXL2) is not required for LOXL2-induced inhibition of keratinocyte differentiation. J. Biol. Chem. 2012, 287:3541-3549.
60. Hong H.H., Pischon N., Santana R.B., Palamakumbura A.H., Chase H.B., Gantz D., Guo Y., Uzel M.I., Ma D., Trackman P.C. A role for lysyl oxidase regulation in the control of normal collagen deposition in differentiating osteoblast cultures. J. Cell. Physiol. 2004, 200:53-62.
61. Sharma-Bhandari A., Park S.H., Kim J.Y., Oh J., Kim Y. Lysyl oxidase modulates the osteoblast differentiation of primary mouse calvaria cells. Int. J. Mol. Med. 2015, 36:1664-1670.
62. Pischon N., Maki J.M., Weisshaupt P., Heng N., Palamakumbura A.H., N'Guessan P., Ding A., Radlanski R., Renz H., Bronckers T.A., Myllyharju J., Kielbassa A.M., Kleber B.M., Bernimoulin J.P., Trackman P.C. Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype. Calcif. Tissue Int. 2009, 85:119-126.
63. Alsofi L., Daley E., Hornstra I., Morgan E.F., Mason Z.D., Acevedo J.F., Word R.A., Gerstenfeld L.C., Trackman P.C. Sex-linked skeletal phenotype of lysyl oxidase like-1 mutant mice. Calcif. Tissue Int. 2015, 10.1007/s00223-015-0076-4.
64. Bais M., McLean J., Sebastiani P., Young M., Wigner N., Smith T., Kotton D.N., Einhorn T.A., Gerstenfeld L.C. Transcriptional analysis of fracture healing and the induction of embryonic stem cell-related genes. PLoS ONE 2009, 4.
65. Iftikhar M., Hurtado P., Bais M.V., Wigner N., Stephens D.N., Gerstenfeld L.C., Trackman P.C. Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation. J. Biol. Chem. 2011, 286:909-918.
66. Atsawasuwan P., Mochida Y., Parisuthiman D., Yamauchi M. Expression of lysyl oxidase isoforms in MC3T3-E1 osteoblastic cells. Biochem. Biophys. Res. Commun. 2005, 327:1042-1046.
67. Saito M., Fujii K., Mori Y., Marumo K. Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos. Int. 2006, 17:1514-1523.
68. Saito M., Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos. Int. 2010, 21:195-214.
69. Saito M., Marumo K. Bone quality in diabetes. Front. Endocrinol. 2013, 4:72.
70. Vlassara H. The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab. Res. Rev. 2001, 17:436-443.
71. Litwinoff E., Hurtado Del Pozo C., Ramasamy R., Schmidt A.M. Emerging targets for therapeutic development in diabetes and its complications: the RAGE signaling pathway. Clin. Pharmacol. Ther. 2015, 98:135-144.
72. Khosravi R., Sodek K.L., Faibish M., Trackman P.C. Collagen advanced glycation inhibits its Discoidin Domain Receptor 2 (DDR2)-mediated induction of lysyl oxidase in osteoblasts. Bone 2014, 58:33-41.
73. Khosravi R., Trackman P.C. Diabetes-induced fibrotic matrix inhibits intramembranous bone healing. J. Cell Commun. Signal. 2014, 10.1007/s12079-014-0242-x.
74. Khosravi R., Sodek K.L., Xu W.P., Bais M.V., Saxena D., Faibish M., Trackman P.C. A novel function for lysyl oxidase in pluripotent mesenchymal cell proliferation and relevance to inflammation-associated osteopenia. PLoS ONE 2014, 9.
75. Huang H., Song T.J., Li X., Hu L., He Q., Liu M., Lane M.D., Tang Q.Q. BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:12670-12675.
76. Halberg N., Khan T., Trujillo M.E., Wernstedt-Asterholm I., Attie A.D., Sherwani S., Wang Z.V., Landskroner-Eiger S., Dineen S., Magalang U.J., Brekken R.A., Scherer P.E. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol. Cell. Biol. 2009, 29:4467-4483.
77. Eliades A., Papadantonakis N., Bhupatiraju A., Burridge K.A., Johnston-Cox H.A., Migliaccio A.R., Crispino J.D., Lucero H.A., Trackman P.C., Ravid K. Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase. J. Biol. Chem. 2011, 286:27630-27638.
78. Lucero H.A., Ravid K., Grimsby J.L., Rich C.B., DiCamillo S.J., Maki J.M., Myllyharju J., Kagan H.M. Lysyl oxidase oxidizes cell membrane proteins and enhances the chemotactic response of vascular smooth muscle cells. J. Biol. Chem. 2008, 283:24103-24117.
79. Wan L., Zhang F., He Q., Tsang W.P., Lu L., Li Q., Wu Z., Qiu G., Zhou G., Wan C. EPO promotes bone repair through enhanced cartilaginous callus formation and angiogenesis. PLoS ONE 2014, 9.
80. Bailey A.J., Sims T.J., Light N. Cross-linking in type IV collagen. Biochem. J. 1984, 218:713-723.
81. Martin A., Salvador F., Moreno-Bueno G., Floristan A., Ruiz-Herguido C., Cuevas E.P., Morales S., Santos V., Csiszar K., Dubus P., Haigh J.J., Bigas A., Portillo F., Cano A. Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression. EMBO J. 2015, 34:1090-1109.
82. Zhang J., Yang R., Liu Z., Hou C., Zong W., Zhang A., Sun X., Gao J. Loss of lysyl oxidase-like 3 causes cleft palate and spinal deformity in mice. Hum. Mol. Genet. 2015, 24:6174-6185.
83. Alzahrani F., Al Hazzaa S.A., Tayeb H., Alkuraya F.S. LOXL3, encoding lysyl oxidase-like 3, is mutated in a family with autosomal recessive Stickler syndrome. Hum. Genet. 2015, 134:451-453.
84. Ito H., Akiyama H., Iguchi H., Iyama K., Miyamoto M., Ohsawa K., Nakamura T. Molecular cloning and biological activity of a novel lysyl oxidase-related gene expressed in cartilage. J. Biol. Chem. 2001, 276:24023-24029.
85. Mäki J.M., Tikkanen H., Kivirikko K.I. Cloning and characterization of a fifth human lysyl oxidase isoenzyme: the third member of the lysyl oxidase-related subfamily with four scavenger receptor cysteine-rich domains. Matrix Biol. 2001, 20:493-496.
86. Gothard D., Greenhough J., Ralph E., Oreffo R.O. Prospective isolation of human bone marrow stromal cell subsets: a comparative study between Stro-1-, CD146- and CD105-enriched populations. J. Tissue Eng. 2014, 5:1-17.
87. Min C., Kirsch K.H., Zhao Y., Jeay S., Palamakumbura A.H., Trackman P.C., Sonenshein G.E. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer. Cancer Res. 2007, 67:1105-1112.
88. Palamakumbura A.H., Jeay S., Guo Y., Pischon N., Sommer P., Sonenshein G.E., Trackman P.C. The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells. J. Biol. Chem. 2004, 279:40593-40600.
89. Barker H.E., Cox T.R., Erler J.T. The rationale for targeting the LOX family in cancer. Nat. Rev. Cancer 2012, 12:540-552.
90. Ulmert D., Solnes L., Thorek D. Contemporary approaches for imaging skeletal metastasis. Bone Res. 2015, 3:15024.
91. Cox T.R., Rumney R.M., Schoof E.M., Perryman L., Hoye A.M., Agrawal A., Bird D., Latif N.A., Forrest H., Evans H.R., Huggins I.D., Lang G., Linding R., Gartland A., Erler J.T. The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature 2015, 522:106-110.
92. Alsulaiman M., Bais M.V., Trackman P.C. Lysyl oxidase propeptide stimulates osteoblast and osteoclast differentiation and enhances PC3 and DU145 prostate cancer cell effects on bone in vivo. J. Cell Commun. Signal. 2015, 10.1007/s12079-015-0311-9.
93. Vora S.R., Palamakumbura A.H., Mitsi M., Guo Y., Pischon N., Nugent M.A., Trackman P.C. Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts. J. Biol. Chem. 2010, 285:7384-7393.
94. Nishida T., Emura K., Kubota S., Lyons K.M., Takigawa M. CCN family 2/connective tissue growth factor (CCN2/CTGF) promotes osteoclastogenesis via induction of and interaction with dendritic cell-specific transmembrane protein (DC-STAMP). J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2011, 26:351-363.
95. Shalhoub V., Faust J., Boyle W.J., Dunstan C.R., Kelley M., Kaufman S., Scully S., Van G., Lacey D.L. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. J. Cell. Biochem. 1999, 72:251-261.
96. El-Haibi C.P., Bell G.W., Zhang J., Collmann A.Y., Wood D., Scherber C.M., Csizmadia E., Mariani O., Zhu C., Campagne A., Toner M., Bhatia S.N., Irimia D., Vincent-Salomon A., Karnoub A.E. Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:17460-17465.
97. Valastyan S., Weinberg R.A. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292.